Synairgen (SNG)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

6.62p
   
  • Change Today:
      0.76p
  • 52 Week High: 9.80
  • 52 Week Low: 4.88
  • Currency: UK Pounds
  • Shares Issued: 201.37m
  • Volume: 273,491
  • Market Cap: £13.33m
  • RiskGrade: 510

ShareCast News

Synairgen expands Covid-19 trial nationwide 18-Jun-2020 ShareCast
Sunday share tips: Synairgen, Hollywood Bowl 29-Mar-2020 ShareCast
Sunday newspaper round-up: Restrictions, Unemplo... 29-Mar-2020 ShareCast
Synairgen to begin trial of potential Covid-19 t... 18-Mar-2020 ShareCast
Synairgen broadens SNG001 trial after committee ... 14-Mar-2019 ShareCast
Synairgen begins second part of SNG001 Phase II ... 22-Oct-2018 ShareCast
Synairgen shares jump as COPD drug trial indicat... 28-Jun-2018 ShareCast
Synairgen lung disease drug 'well tolerated' in ... 22-Jun-2018 ShareCast
Synairgen doses first patients in SNG001 trial 07-Feb-2018 ShareCast
Synairgen shares rise after announcing 'excellen... 27-Sep-2017 ShareCast
Synairgen upbeat on recent LOXL2 inhibitor findi... 06-Sep-2017 ShareCast
Synairgen's shares dive after AstraZeneca return... 27-Apr-2017 ShareCast
Synairgen shares drop as AstraZeneca stops asthm... 12-Oct-2016 ShareCast
Synairgen's profit dips, R and D expenditure red... 16-Sep-2015 ShareCast
Synairgen shares surge on research collaboration... 05-Aug-2015 ShareCast
AstraZeneca starts next phase of testing on Syna... 22-Jul-2015 ShareCast
Tuesday broker round-up UPDATE 21-Oct-2014 ShareCast
Synairgen raises funds to develop AstraZeneca drug 04-Jul-2014 ShareCast
Sunday share tips: Whitbread, Petra Diamonds, Em... 15-Jun-2014 ShareCast
London open: Mining stocks pull FTSE 100 lower a... 12-Jun-2014 ShareCast
AstraZeneca signs licence deal with Synairgen 12-Jun-2014 ShareCast
Synairgen reports 'significant progress' 05-Dec-2012 ShareCast
Synairgen raises 2.5m pounds from placing 18-Jul-2012 ShareCast
Synairgen no wheeze as asthma drug trial boosts ... 19-Apr-2012 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Synairgen Market Data

Currency UK Pounds
Share Price 6.62p
Change Today 0.76p
% Change 12.97 %
52 Week High 9.80
52 Week Low 4.88
Volume 273,491
Shares Issued 201.37m
Market Cap £13.33m
RiskGrade 510

Synairgen Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
59.10% above the market average59.10% above the market average59.10% above the market average59.10% above the market average59.10% above the market average
68.63% above the sector average68.63% above the sector average68.63% above the sector average68.63% above the sector average68.63% above the sector average
Price Trend
52.63% below the market average52.63% below the market average52.63% below the market average52.63% below the market average52.63% below the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 1
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Synairgen Dividends

No dividends found

Trades for 10-May-2024

Time Volume / Share Price
16:29 2,308 @ 6.93p
16:27 43,593 @ 6.86p
15:50 38,000 @ 6.50p
15:50 8,000 @ 6.50p
15:50 30,000 @ 6.50p

Synairgen Key Personnel

CEO Richard J Marsden

Top of Page